Ascendis Pharma A/S American Depositary Shares

Go to Ascendis Pharma A/S American Depositary Shares Website

$186.59

0.00 (0.00%)
Live
Previous Close

$186.59

Day Range

$0 - $0

Previous Day Range

$180.705 - $186.89

Market Cap

$11.1 billion USD

Day Vol.

0

Previous Day Vol.

650266

Currency

USD

Primary Exchange

Nasdaq

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, a...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

BioMarin Pharmaceutical reported strong Q4 earnings, beating consensus estimates for both EPS and revenue. The company provided upbeat 2025 guidance, expecting sales of $3.1-$3.2 billion and EPS of $4.20-$4.40.

Related tickers: BMRN, ASND.

Read Full Article

Ascendis Pharma granted Novo Nordisk an exclusive global license to develop, manufacture, and commercialize Novo Nordisk's proprietary products for metabolic and cardiovascular diseases using Ascendis' TransCon technology platform. The deal includes upfront, milestone, and sales-based payments for Ascendis.

Related tickers: ASND.

Read Full Article
Trending Tickers

Please sign in to view